Genistein and cAMP signaling in vascular endothelium
Genistein and cAMP signaling in vascular endothelium
批准号:
7140738
负责人:
DONGMIN LIU
金额:
$19.98万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2009-04-30
关键词:
AddressAdenylate CyclaseAdhesionsAgingAmericanAnimalsArteriosclerosisBiochemicalBiologicalBiological AssayBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemCell ProliferationCell membraneCellsChronicConditionCyclic AMPCyclic AMP-Dependent Protein KinasesCytoskeletal ModelingDataDepressed moodDevelopmentDiseaseDoseElevationEndothelial CellsEstrogen ReceptorsEventExtravasationFoundationsFunctional disorderGTP-Binding ProteinsGasesGene ExpressionGenetic TranscriptionGenisteinGenomicsGoalsHealthHealth BenefitHypertensionHypotensionIngestionInterventionIsoflavonesLeukocytesMediatingMediationMessenger RNAMethodsMicroscopeMolecularMorbidity - disease rateNitric OxideNitric Oxide SynthaseNutraceuticalPathway interactionsPermeabilityPhysiologicalPlayPolymerase Chain ReactionPopulationPreventiveProcessProductionProtein BiosynthesisProtein Tyrosine KinaseProteinsPublic HealthRNARangeRattusResearchRibonucleasesRoleSignal PathwaySignal TransductionSignaling MoleculeSmooth Muscle MyocytesSoy ProteinsSystemTestingTherapeuticThrombinTimeVascular DiseasesVascular Endothelial CellVascular Endotheliumanalogbasecellular targetingdietary supplementshuman NOS3 proteinimmunocytochemistrymonolayernon-genomicnovelpromoterprotective effectprotein expressionsoysoy protein isolatevasoactive agent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-range goal of this research is to develop novel vasoactive agents that may be of benefit in lowering the high level of cardiovascular morbidity in the aging American population. Recent studies have shown that ingestion of soy protein associated with isoflavones may have a protective role in vasculature. Genistein, the major soy isoflavone, has various biologgical actions. However, it is not clear whether the beneficial effect of soy protein is due to genistein or other components. In addition, the cellular or molecular mechanisms underlying the vessel protective effect of soy products remain unclear. We recently found that genistein directly acts on vascular dothelial cells (EC), leading to cAMP accumulation, nitric oxide synthase (eNOS) activation and expression. Further, We demonstrated that genistein induced a rapid decrease in systemic blood pressure (BP) in rats. The objective of this application, is therefore to determine how genistein triggers the cAMP signaling pathway and thereby influencing the cAMP-related vascular function. The four following questions will be addressed: 1). How does genistein elevate cAMP, activate eNOS, and consequently stimulate nitric oxide in EC? 2) Does genistein decrease BP in animals through activation of the cAMP signaling? 3). Does elevated cAMP by genistein also alter eNOS gene expression ? 4). Does genistein protect endothelial barrier function via the cAMP signaling? We will employ cellular, molecular and biochemical analysis to determine whether genistein elevates cAMP via activation of Gs-mediated adenylate cyclase in EC. Genistein-regulated eNOS gene expression will be evaluated by ribonuclease protection assay and Real-Time PCR. The effect of genistein on endothelial barrier function, as determined by cytoskeletal reorganization and barrier permeability, will be assessed using immunocytochemistry, confocal microscope and macromolecular leakage methods. Pharmacological and molecular intervention approaches will be used to detemine the involvement of a specific pathway in mediation of genistein action. The results from these studies will establish the mechanisms of the genistein action in vasculature and thereby provide foundation for further studies to determine the effects of genistein on vascular health and diseases such as hypertension. The demonstration of the health benefits of soy isoflavones in vasculature is expected to have significant effect on public health since isoflavones are widely used as a dietary supplements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and characterization of a novel natural product for the treatment of both diabetes and obesity
-
批准号:10737170
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2023
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8820798
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8234308
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8619589
-
项目类别:
-
资助金额:$37.99万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Identification and molecular characterization of anti-diabetic flavonoids
-
批准号:8427297
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2012
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the prevention and treatment of diabetic vascular inflammation
-
批准号:7816316
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2009
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation
-
批准号:7509977
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2008
-
负责人:DONGMIN LIU
-
依托单位:
Genistein for the Prevention and Treatment of Diabetic Vascular Inflammation
-
批准号:7686348
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2008
-
负责人:DONGMIN LIU
-
依托单位:
Genistein and cAMP signaling in vascular endothelium
-
批准号:7491164
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2007
-
负责人:DONGMIN LIU
-
依托单位:
海外基金